nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—HTR2C—metabolic syndrome X	0.432	1	CbGaD
Imipramine—SLC22A3—Metformin—metabolic syndrome X	0.169	0.475	CbGbCtD
Imipramine—SLC22A2—Metformin—metabolic syndrome X	0.1	0.281	CbGbCtD
Imipramine—SLC22A1—Metformin—metabolic syndrome X	0.0869	0.244	CbGbCtD
Imipramine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00519	0.0749	CbGeAlD
Imipramine—HTR7—sympathetic nervous system—metabolic syndrome X	0.005	0.0722	CbGeAlD
Imipramine—HTR2A—arteriole—metabolic syndrome X	0.0049	0.0706	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00349	0.0503	CbGeAlD
Imipramine—HTR7—autonomic nervous system—metabolic syndrome X	0.00336	0.0485	CbGeAlD
Imipramine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00312	0.045	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—metabolic syndrome X	0.0021	0.0303	CbGeAlD
Imipramine—KCND2—cardiovascular system—metabolic syndrome X	0.00192	0.0277	CbGeAlD
Imipramine—HTR7—artery—metabolic syndrome X	0.00191	0.0275	CbGeAlD
Imipramine—KCND2—adipose tissue—metabolic syndrome X	0.00169	0.0244	CbGeAlD
Imipramine—KCND3—cardiovascular system—metabolic syndrome X	0.00167	0.0241	CbGeAlD
Imipramine—HTR7—endothelium—metabolic syndrome X	0.00161	0.0232	CbGeAlD
Imipramine—HTR7—blood vessel—metabolic syndrome X	0.00149	0.0214	CbGeAlD
Imipramine—KCND3—adipose tissue—metabolic syndrome X	0.00147	0.0213	CbGeAlD
Imipramine—HTR2A—artery—metabolic syndrome X	0.00119	0.0172	CbGeAlD
Imipramine—SLC22A2—kidney—metabolic syndrome X	0.00116	0.0168	CbGeAlD
Imipramine—ADRA1B—kidney—metabolic syndrome X	0.00111	0.0161	CbGeAlD
Imipramine—KCND3—liver—metabolic syndrome X	0.00103	0.0149	CbGeAlD
Imipramine—HTR2A—endothelium—metabolic syndrome X	0.001	0.0145	CbGeAlD
Imipramine—CYP2C18—liver—metabolic syndrome X	0.000942	0.0136	CbGeAlD
Imipramine—HTR2A—blood vessel—metabolic syndrome X	0.000926	0.0134	CbGeAlD
Imipramine—CYP3A7—liver—metabolic syndrome X	0.000896	0.0129	CbGeAlD
Imipramine—SLC22A4—kidney—metabolic syndrome X	0.000863	0.0124	CbGeAlD
Imipramine—CHRM2—cardiovascular system—metabolic syndrome X	0.000855	0.0123	CbGeAlD
Imipramine—SLC22A1—kidney—metabolic syndrome X	0.000821	0.0118	CbGeAlD
Imipramine—SLC22A3—kidney—metabolic syndrome X	0.000785	0.0113	CbGeAlD
Imipramine—CHRM1—cardiovascular system—metabolic syndrome X	0.000778	0.0112	CbGeAlD
Imipramine—SLC22A4—adipose tissue—metabolic syndrome X	0.000777	0.0112	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.000762	0.011	CbGeAlD
Imipramine—Liver function test abnormal—Metformin—metabolic syndrome X	0.000743	0.0322	CcSEcCtD
Imipramine—SLC22A1—adipose tissue—metabolic syndrome X	0.00074	0.0107	CbGeAlD
Imipramine—Breast disorder—Metformin—metabolic syndrome X	0.000727	0.0315	CcSEcCtD
Imipramine—SLC22A3—adipose tissue—metabolic syndrome X	0.000708	0.0102	CbGeAlD
Imipramine—HTR1A—cardiovascular system—metabolic syndrome X	0.000693	0.01	CbGeAlD
Imipramine—CHRM3—kidney—metabolic syndrome X	0.000681	0.00983	CbGeAlD
Imipramine—HTR7—cardiovascular system—metabolic syndrome X	0.000663	0.00956	CbGeAlD
Imipramine—HTR7—kidney—metabolic syndrome X	0.000648	0.00935	CbGeAlD
Imipramine—ADRA1A—cardiovascular system—metabolic syndrome X	0.000639	0.00922	CbGeAlD
Imipramine—Infestation—Metformin—metabolic syndrome X	0.00062	0.0268	CcSEcCtD
Imipramine—Infestation NOS—Metformin—metabolic syndrome X	0.00062	0.0268	CcSEcCtD
Imipramine—Drowsiness—Metformin—metabolic syndrome X	0.00062	0.0268	CcSEcCtD
Imipramine—KCNH2—cardiovascular system—metabolic syndrome X	0.000617	0.0089	CbGeAlD
Imipramine—CHRM3—adipose tissue—metabolic syndrome X	0.000614	0.00886	CbGeAlD
Imipramine—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000608	0.0263	CcSEcCtD
Imipramine—ABCB1—blood vessel—metabolic syndrome X	0.000607	0.00876	CbGeAlD
Imipramine—Benazepril—ACE—metabolic syndrome X	0.000597	0.122	CrCbGaD
Imipramine—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000586	0.0254	CcSEcCtD
Imipramine—ORM1—liver—metabolic syndrome X	0.000567	0.00818	CbGeAlD
Imipramine—ADRA1A—adipose tissue—metabolic syndrome X	0.000564	0.00813	CbGeAlD
Imipramine—Hepatitis—Metformin—metabolic syndrome X	0.000556	0.0241	CcSEcCtD
Imipramine—Hypoaesthesia—Metformin—metabolic syndrome X	0.000554	0.024	CcSEcCtD
Imipramine—Eye disorder—Metformin—metabolic syndrome X	0.00052	0.0225	CcSEcCtD
Imipramine—SLC22A1—liver—metabolic syndrome X	0.000519	0.00749	CbGeAlD
Imipramine—Flushing—Metformin—metabolic syndrome X	0.000516	0.0224	CcSEcCtD
Imipramine—Cardiac disorder—Metformin—metabolic syndrome X	0.000516	0.0224	CcSEcCtD
Imipramine—CYP2B6—cardiovascular system—metabolic syndrome X	0.000507	0.00731	CbGeAlD
Imipramine—Angiopathy—Metformin—metabolic syndrome X	0.000505	0.0219	CcSEcCtD
Imipramine—Immune system disorder—Metformin—metabolic syndrome X	0.000503	0.0218	CcSEcCtD
Imipramine—Cyamemazine—HTR2C—metabolic syndrome X	0.000502	0.103	CrCbGaD
Imipramine—Mediastinal disorder—Metformin—metabolic syndrome X	0.000502	0.0217	CcSEcCtD
Imipramine—SLC22A3—liver—metabolic syndrome X	0.000496	0.00716	CbGeAlD
Imipramine—CYP2B6—kidney—metabolic syndrome X	0.000496	0.00715	CbGeAlD
Imipramine—Malnutrition—Metformin—metabolic syndrome X	0.000484	0.021	CcSEcCtD
Imipramine—CYP2E1—cardiovascular system—metabolic syndrome X	0.000475	0.00686	CbGeAlD
Imipramine—Dysgeusia—Metformin—metabolic syndrome X	0.000474	0.0205	CcSEcCtD
Imipramine—CYP2E1—kidney—metabolic syndrome X	0.000465	0.00671	CbGeAlD
Imipramine—Vision blurred—Metformin—metabolic syndrome X	0.000457	0.0198	CcSEcCtD
Imipramine—Tremor—Metformin—metabolic syndrome X	0.000454	0.0197	CcSEcCtD
Imipramine—Ill-defined disorder—Metformin—metabolic syndrome X	0.000449	0.0195	CcSEcCtD
Imipramine—Malaise—Metformin—metabolic syndrome X	0.000437	0.0189	CcSEcCtD
Imipramine—HRH1—adipose tissue—metabolic syndrome X	0.000436	0.00629	CbGeAlD
Imipramine—Syncope—Metformin—metabolic syndrome X	0.000434	0.0188	CcSEcCtD
Imipramine—Palpitations—Metformin—metabolic syndrome X	0.000428	0.0185	CcSEcCtD
Imipramine—Loss of consciousness—Metformin—metabolic syndrome X	0.000426	0.0184	CcSEcCtD
Imipramine—Hypertension—Metformin—metabolic syndrome X	0.000418	0.0181	CcSEcCtD
Imipramine—HTR2A—cardiovascular system—metabolic syndrome X	0.000413	0.00596	CbGeAlD
Imipramine—HTR7—liver—metabolic syndrome X	0.00041	0.00591	CbGeAlD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00041	0.0177	CcSEcCtD
Imipramine—Discomfort—Metformin—metabolic syndrome X	0.000407	0.0176	CcSEcCtD
Imipramine—HTR2A—kidney—metabolic syndrome X	0.000404	0.00583	CbGeAlD
Imipramine—CYP2C19—liver—metabolic syndrome X	0.0004	0.00577	CbGeAlD
Imipramine—Maprotiline—HTR2C—metabolic syndrome X	0.000399	0.0816	CrCbGaD
Imipramine—Oedema—Metformin—metabolic syndrome X	0.000395	0.0171	CcSEcCtD
Imipramine—ADRA1A—liver—metabolic syndrome X	0.000395	0.0057	CbGeAlD
Imipramine—Infection—Metformin—metabolic syndrome X	0.000393	0.017	CcSEcCtD
Imipramine—Shock—Metformin—metabolic syndrome X	0.000389	0.0168	CcSEcCtD
Imipramine—Nervous system disorder—Metformin—metabolic syndrome X	0.000388	0.0168	CcSEcCtD
Imipramine—Thrombocytopenia—Metformin—metabolic syndrome X	0.000387	0.0168	CcSEcCtD
Imipramine—Skin disorder—Metformin—metabolic syndrome X	0.000384	0.0166	CcSEcCtD
Imipramine—Hyperhidrosis—Metformin—metabolic syndrome X	0.000382	0.0166	CcSEcCtD
Imipramine—Anorexia—Metformin—metabolic syndrome X	0.000377	0.0163	CcSEcCtD
Imipramine—CYP3A4—kidney—metabolic syndrome X	0.000374	0.0054	CbGeAlD
Imipramine—CYP2D6—kidney—metabolic syndrome X	0.000368	0.00531	CbGeAlD
Imipramine—Paraesthesia—Metformin—metabolic syndrome X	0.000355	0.0154	CcSEcCtD
Imipramine—Somnolence—Metformin—metabolic syndrome X	0.000351	0.0152	CcSEcCtD
Imipramine—Dyspepsia—Metformin—metabolic syndrome X	0.000348	0.0151	CcSEcCtD
Imipramine—Decreased appetite—Metformin—metabolic syndrome X	0.000344	0.0149	CcSEcCtD
Imipramine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000341	0.0148	CcSEcCtD
Imipramine—Fatigue—Metformin—metabolic syndrome X	0.000341	0.0148	CcSEcCtD
Imipramine—Constipation—Metformin—metabolic syndrome X	0.000338	0.0146	CcSEcCtD
Imipramine—CYP1A2—liver—metabolic syndrome X	0.000327	0.00471	CbGeAlD
Imipramine—Feeling abnormal—Metformin—metabolic syndrome X	0.000326	0.0141	CcSEcCtD
Imipramine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000323	0.014	CcSEcCtD
Imipramine—Urticaria—Metformin—metabolic syndrome X	0.000314	0.0136	CcSEcCtD
Imipramine—CYP2B6—liver—metabolic syndrome X	0.000313	0.00452	CbGeAlD
Imipramine—Abdominal pain—Metformin—metabolic syndrome X	0.000313	0.0135	CcSEcCtD
Imipramine—Prochlorperazine—HTR2C—metabolic syndrome X	0.000296	0.0606	CrCbGaD
Imipramine—CYP2E1—liver—metabolic syndrome X	0.000294	0.00424	CbGeAlD
Imipramine—Asthenia—Metformin—metabolic syndrome X	0.000284	0.0123	CcSEcCtD
Imipramine—Pruritus—Metformin—metabolic syndrome X	0.00028	0.0121	CcSEcCtD
Imipramine—ABCB1—cardiovascular system—metabolic syndrome X	0.000271	0.00391	CbGeAlD
Imipramine—Diarrhoea—Metformin—metabolic syndrome X	0.00027	0.0117	CcSEcCtD
Imipramine—Mianserin—HTR2C—metabolic syndrome X	0.000268	0.0548	CrCbGaD
Imipramine—ABCB1—kidney—metabolic syndrome X	0.000265	0.00382	CbGeAlD
Imipramine—Dizziness—Metformin—metabolic syndrome X	0.000261	0.0113	CcSEcCtD
Imipramine—HTR2A—liver—metabolic syndrome X	0.000256	0.00369	CbGeAlD
Imipramine—Vomiting—Metformin—metabolic syndrome X	0.000251	0.0109	CcSEcCtD
Imipramine—Rash—Metformin—metabolic syndrome X	0.000249	0.0108	CcSEcCtD
Imipramine—Dermatitis—Metformin—metabolic syndrome X	0.000249	0.0108	CcSEcCtD
Imipramine—Headache—Metformin—metabolic syndrome X	0.000248	0.0107	CcSEcCtD
Imipramine—Clomipramine—HTR2C—metabolic syndrome X	0.000245	0.0502	CrCbGaD
Imipramine—Nortriptyline—HTR2C—metabolic syndrome X	0.000239	0.049	CrCbGaD
Imipramine—ABCB1—adipose tissue—metabolic syndrome X	0.000239	0.00344	CbGeAlD
Imipramine—CYP3A4—liver—metabolic syndrome X	0.000237	0.00341	CbGeAlD
Imipramine—Nausea—Metformin—metabolic syndrome X	0.000235	0.0102	CcSEcCtD
Imipramine—CYP2D6—liver—metabolic syndrome X	0.000233	0.00336	CbGeAlD
Imipramine—Trimipramine—HTR2C—metabolic syndrome X	0.000225	0.0462	CrCbGaD
Imipramine—Methotrimeprazine—HTR2C—metabolic syndrome X	0.00022	0.0451	CrCbGaD
Imipramine—Doxepin—HTR2C—metabolic syndrome X	0.000215	0.044	CrCbGaD
Imipramine—Desipramine—HTR2C—metabolic syndrome X	0.000197	0.0404	CrCbGaD
Imipramine—Promazine—HTR2C—metabolic syndrome X	0.000191	0.0391	CrCbGaD
Imipramine—Oxcarbazepine—ALB—metabolic syndrome X	0.000186	0.0381	CrCbGaD
Imipramine—Chlorpromazine—HTR2C—metabolic syndrome X	0.000168	0.0344	CrCbGaD
Imipramine—ABCB1—liver—metabolic syndrome X	0.000167	0.00242	CbGeAlD
Imipramine—Amitriptyline—HTR2C—metabolic syndrome X	0.000166	0.034	CrCbGaD
Imipramine—Acepromazine—ALB—metabolic syndrome X	0.00014	0.0288	CrCbGaD
Imipramine—Thioproperazine—ALB—metabolic syndrome X	0.000137	0.0281	CrCbGaD
Imipramine—Pipotiazine—ALB—metabolic syndrome X	0.000135	0.0277	CrCbGaD
Imipramine—Clomipramine—ALB—metabolic syndrome X	0.000107	0.0219	CrCbGaD
Imipramine—Nortriptyline—ALB—metabolic syndrome X	0.000104	0.0214	CrCbGaD
Imipramine—Chlorpromazine—ALB—metabolic syndrome X	7.32e-05	0.015	CrCbGaD
Imipramine—Amitriptyline—ALB—metabolic syndrome X	7.24e-05	0.0148	CrCbGaD
Imipramine—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	6.68e-06	5.84e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	6.65e-06	5.81e-05	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—AKT1—metabolic syndrome X	6.61e-06	5.78e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	6.6e-06	5.77e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	6.59e-06	5.76e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	6.58e-06	5.75e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOB—metabolic syndrome X	6.57e-06	5.74e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	6.54e-06	5.72e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—metabolic syndrome X	6.51e-06	5.69e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ALB—metabolic syndrome X	6.49e-06	5.67e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	6.47e-06	5.66e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.45e-06	5.64e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—LPL—metabolic syndrome X	6.42e-06	5.62e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	6.39e-06	5.59e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	6.38e-06	5.58e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	6.38e-06	5.58e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	6.37e-06	5.57e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	6.37e-06	5.57e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	6.36e-06	5.56e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	6.36e-06	5.56e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.34e-06	5.55e-05	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—AKT1—metabolic syndrome X	6.33e-06	5.54e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	6.33e-06	5.54e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	6.33e-06	5.54e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GCK—metabolic syndrome X	6.33e-06	5.54e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	6.31e-06	5.52e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	6.29e-06	5.5e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—LPL—metabolic syndrome X	6.27e-06	5.48e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—metabolic syndrome X	6.24e-06	5.45e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	6.23e-06	5.45e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	6.22e-06	5.44e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PPARG—metabolic syndrome X	6.21e-06	5.43e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—NOS3—metabolic syndrome X	6.21e-06	5.43e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	6.2e-06	5.42e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOB—metabolic syndrome X	6.19e-06	5.41e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	6.18e-06	5.4e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	6.18e-06	5.4e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	6.18e-06	5.4e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PTGS2—metabolic syndrome X	6.14e-06	5.37e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	6.12e-06	5.35e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CETP—metabolic syndrome X	6.11e-06	5.34e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CD36—metabolic syndrome X	6.1e-06	5.34e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	6.1e-06	5.34e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—INS—metabolic syndrome X	6.09e-06	5.32e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PPARG—metabolic syndrome X	6.08e-06	5.32e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—INS—metabolic syndrome X	6.06e-06	5.3e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	6.06e-06	5.3e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	6.04e-06	5.28e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	6.03e-06	5.27e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	6.02e-06	5.26e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	6.01e-06	5.25e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	5.97e-06	5.22e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	5.97e-06	5.22e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—INS—metabolic syndrome X	5.96e-06	5.21e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CD36—metabolic syndrome X	5.96e-06	5.21e-05	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	5.96e-06	5.21e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—INS—metabolic syndrome X	5.95e-06	5.21e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—INS—metabolic syndrome X	5.94e-06	5.19e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—INS—metabolic syndrome X	5.92e-06	5.17e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—LPL—metabolic syndrome X	5.91e-06	5.17e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	5.87e-06	5.13e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	5.87e-06	5.13e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	5.86e-06	5.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—INS—metabolic syndrome X	5.86e-06	5.12e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	5.86e-06	5.12e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.85e-06	5.11e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	5.84e-06	5.11e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	5.84e-06	5.11e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	5.82e-06	5.09e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	5.77e-06	5.05e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	5.77e-06	5.04e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	5.76e-06	5.04e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	5.76e-06	5.04e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	5.75e-06	5.03e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	5.75e-06	5.03e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	5.74e-06	5.02e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	5.72e-06	5e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	5.68e-06	4.96e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PTGS2—metabolic syndrome X	5.68e-06	4.96e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARA—metabolic syndrome X	5.67e-06	4.96e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	5.67e-06	4.96e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	5.65e-06	4.94e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CD36—metabolic syndrome X	5.61e-06	4.91e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ALB—metabolic syndrome X	5.58e-06	4.88e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	5.57e-06	4.87e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARA—metabolic syndrome X	5.54e-06	4.84e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	5.52e-06	4.83e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	5.52e-06	4.83e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AGT—metabolic syndrome X	5.5e-06	4.81e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	5.48e-06	4.79e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	5.47e-06	4.78e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ALB—metabolic syndrome X	5.47e-06	4.78e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	5.45e-06	4.77e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	5.43e-06	4.75e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	5.41e-06	4.73e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	5.41e-06	4.73e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	5.41e-06	4.73e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APOE—metabolic syndrome X	5.38e-06	4.71e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	5.38e-06	4.71e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	5.37e-06	4.69e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AGT—metabolic syndrome X	5.36e-06	4.69e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—NOS3—metabolic syndrome X	5.34e-06	4.67e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APOA1—metabolic syndrome X	5.32e-06	4.65e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	5.32e-06	4.65e-05	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AKT1—metabolic syndrome X	5.28e-06	4.62e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOE—metabolic syndrome X	5.26e-06	4.6e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOB—metabolic syndrome X	5.24e-06	4.58e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	5.23e-06	4.58e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—NOS3—metabolic syndrome X	5.23e-06	4.57e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	5.22e-06	4.57e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	5.22e-06	4.56e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	5.21e-06	4.55e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOA1—metabolic syndrome X	5.2e-06	4.54e-05	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.19e-06	4.54e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	5.19e-06	4.54e-05	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	5.16e-06	4.52e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	5.14e-06	4.49e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	5.12e-06	4.48e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	5.11e-06	4.47e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	5.1e-06	4.46e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	5.1e-06	4.46e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	5.08e-06	4.44e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AGT—metabolic syndrome X	5.05e-06	4.42e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—LPL—metabolic syndrome X	5.01e-06	4.38e-05	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—metabolic syndrome X	4.99e-06	4.36e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—metabolic syndrome X	4.95e-06	4.33e-05	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	4.94e-06	4.32e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.92e-06	4.3e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.92e-06	4.3e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	4.9e-06	4.28e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	4.89e-06	4.27e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—metabolic syndrome X	4.88e-06	4.27e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	4.87e-06	4.26e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—metabolic syndrome X	4.78e-06	4.18e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.77e-06	4.17e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.77e-06	4.17e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CD36—metabolic syndrome X	4.76e-06	4.16e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	4.71e-06	4.12e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—metabolic syndrome X	4.69e-06	4.1e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	4.69e-06	4.1e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—INS—metabolic syndrome X	4.6e-06	4.02e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	4.6e-06	4.02e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—metabolic syndrome X	4.58e-06	4e-05	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	4.56e-06	3.99e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—INS—metabolic syndrome X	4.49e-06	3.93e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	4.49e-06	3.93e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	4.49e-06	3.92e-05	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	4.48e-06	3.92e-05	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	4.47e-06	3.91e-05	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	4.46e-06	3.9e-05	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	4.45e-06	3.89e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	4.42e-06	3.87e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	4.41e-06	3.86e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	4.4e-06	3.85e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	4.4e-06	3.85e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	4.39e-06	3.84e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	4.39e-06	3.84e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	4.38e-06	3.83e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	4.33e-06	3.79e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	4.32e-06	3.78e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	4.31e-06	3.77e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGT—metabolic syndrome X	4.28e-06	3.74e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—INS—metabolic syndrome X	4.23e-06	3.7e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—metabolic syndrome X	4.22e-06	3.69e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—metabolic syndrome X	4.2e-06	3.67e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	4.15e-06	3.63e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	4.14e-06	3.62e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—metabolic syndrome X	4.12e-06	3.6e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—metabolic syndrome X	4.08e-06	3.57e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—metabolic syndrome X	4.07e-06	3.56e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	4.07e-06	3.56e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	4.06e-06	3.55e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	4.05e-06	3.54e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOB—metabolic syndrome X	4.05e-06	3.54e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	4.04e-06	3.53e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—metabolic syndrome X	4.03e-06	3.53e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	4.01e-06	3.5e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	4e-06	3.5e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	3.99e-06	3.49e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	3.98e-06	3.48e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—metabolic syndrome X	3.94e-06	3.44e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.94e-06	3.44e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—metabolic syndrome X	3.88e-06	3.39e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.86e-06	3.38e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	3.85e-06	3.36e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	3.81e-06	3.34e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	3.76e-06	3.29e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	3.76e-06	3.29e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	3.71e-06	3.24e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	3.69e-06	3.23e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	3.68e-06	3.22e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.67e-06	3.21e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	3.65e-06	3.2e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—metabolic syndrome X	3.6e-06	3.15e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—INS—metabolic syndrome X	3.58e-06	3.13e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	3.55e-06	3.1e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	3.52e-06	3.08e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	3.46e-06	3.03e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	3.46e-06	3.03e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	3.45e-06	3.02e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	3.44e-06	3.01e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	3.43e-06	3e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.41e-06	2.98e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	3.4e-06	2.97e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	3.4e-06	2.97e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	3.39e-06	2.97e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	3.39e-06	2.96e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—metabolic syndrome X	3.32e-06	2.9e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—metabolic syndrome X	3.31e-06	2.9e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGT—metabolic syndrome X	3.3e-06	2.89e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—metabolic syndrome X	3.29e-06	2.87e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—metabolic syndrome X	3.24e-06	2.83e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	3.2e-06	2.8e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	3.19e-06	2.79e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	3.14e-06	2.75e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—metabolic syndrome X	3.09e-06	2.7e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	3.02e-06	2.64e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	3e-06	2.63e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	2.87e-06	2.51e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	2.87e-06	2.51e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—metabolic syndrome X	2.85e-06	2.49e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.82e-06	2.47e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	2.78e-06	2.43e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	2.77e-06	2.42e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—INS—metabolic syndrome X	2.77e-06	2.42e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	2.65e-06	2.32e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	2.65e-06	2.32e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	2.61e-06	2.28e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	2.6e-06	2.28e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	2.59e-06	2.27e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	2.59e-06	2.26e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	2.56e-06	2.24e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	2.55e-06	2.23e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.54e-06	2.22e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—metabolic syndrome X	2.45e-06	2.15e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	2.44e-06	2.14e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.43e-06	2.12e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	2.41e-06	2.1e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—metabolic syndrome X	2.4e-06	2.1e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	2.4e-06	2.1e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	2.39e-06	2.09e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	2.39e-06	2.09e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	2.36e-06	2.07e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	2.36e-06	2.06e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.22e-06	1.94e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.85e-06	1.62e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.81e-06	1.58e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.71e-06	1.49e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	1.44e-06	1.26e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.12e-06	9.75e-06	CbGpPWpGaD
